Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

1(20.0%)

Early Phase 1

1(20.0%)

5Total

N/A(3)

Phase 1(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07097688Phase 1Active Not Recruiting

Regenerative Endodontic Treatment Using Sodium Hexametaphosphate (SHMP) For Necrotic Immature Permanent Anterior Teeth

Role: lead

NCT05878158Early Phase 1Unknown

Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

Role: lead

NCT05522270Not ApplicableUnknown

Concentrated Growth Factor Versus Platelet Rich Fibrin in Revitalization of Necrotic Young Permanent Incisors

Role: lead

NCT04137861Not ApplicableCompleted

Evaluation of Furcal Perforation Repair in Primary Molars With MTA Versus Bioceramics (A Randomized Clinical Trial)

Role: lead

NCT04279041Not ApplicableCompleted

In-vitro and In-vivo Comparative Evaluation of Rotary Fanta and Zunba Files in Root Canal Preparation of Infected Primary Molars

Role: lead

All 5 trials loaded